Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071340
Filing Date
2025-05-14
Accepted
2025-05-14 16:00:25
Documents
65
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-20250331.htm   iXBRL 10-Q 1983046
2 EX-31.1 enta-ex31_1.htm EX-31.1 12358
3 EX-31.2 enta-ex31_2.htm EX-31.2 12308
4 EX-32.1 enta-ex32_1.htm EX-32.1 13293
5 GRAPHIC img217883449_0.jpg GRAPHIC 1452180
  Complete submission text file 0000950170-25-071340.txt   10857017

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT enta-20250331.xsd EX-101.SCH 935446
68 EXTRACTED XBRL INSTANCE DOCUMENT enta-20250331_htm.xml XML 1438302
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 25945063
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)